)
)
Ben DeMeo
Senior Machine Learning Researcher
,
Valid Therapeutics
Benjamin DeMeo is a Senior Machine Learning Researcher at Valid, Inc. He previously spent four years at Cellarity, where he built and deployed foundation models, active-learning workflows, and predictive modeling systems for drug discovery programs. He is the lead author of a 2025 Science paper describing an ML-driven transcriptomics framework for discovering compounds that modulate disease-relevant cellular phenotypes.
Sessions
-
Panel Discussion: From AI Tools to AI Systems: Operationalising AI in Drug Discovery04-Jun-2026AI in Drug Discovery Stage